Tela Bio Inc Reports Results For The Quarter Ended In January: Earnings Summary

TELA Bio

13/08/2024 02:51

* TELA Bio Inc  TELA.OQ  reported a quarterly adjusted loss
of 51
cents​​ per share for the quarter ended in January, lower than
the same quarter last year, when the company reported EPS of -46
cents.  The mean expectation of five analysts for the quarter
was for a loss of 47 cents per share. Wall Street expected
results to range from -51 cents to -43 cents per share.
    * Revenue rose 11% to $16.09 million from a year ago;
analysts
expected $18.46 million. 
    * TELA Bio Inc's reported EPS for the quarter was a loss
of 51
cents​.
    * The company reported a quarterly loss of $12.6 million.
    * TELA Bio Inc shares had fallen by 13.6% this quarter and
lost 38.7% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the medical
equipment,
supplies & distribution peer group is also "buy"

Wall Street's median 12-month price target for TELA Bio Inc is
$14.00 
This summary was machine generated from LSEG data August 13 at
01:51 a.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2024      -0.47          -0.51          Missed
 Mar. 31 2024      -0.50          -0.23          Beat
 Dec. 31 2023      -0.43          -0.53          Missed
 Sep. 30 2023      -0.49          -0.45          Beat